Joanne M Mankor (Joanne Mankor)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Decision Making

Tyrosine Kinase

Top Venues

PharmacoEconomics

Science immunology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Zakile A Mfumbilwa, Martijn J H G Simons, Bram L T Ramaekers, Valesca P Retèl, Joanne M Mankor, Harry J M Groen, Joachim G J V Aerts, Manuela A Joore, Janneke A Wilschut, Veerle M H Coupé
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy. PharmacoEconomics (2024)
Zakile A Mfumbilwa, Martijn J H G Simons, Bram L T Ramaekers, Valesca P Retèl, Joanne M Mankor, Harry J M Groen, Joachim G J V Aerts, Manuela A Joore, Janneke A Wilschut, Veerle M H Coupé
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy. PharmacoEconomics 42 (4) (2024)
Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, Kim Monkhorst, Egbert F Smit, Lodewyk F A Wessels, Edwin Cuppen, Joachim G J V Aerts, Emile E Voest
Combining Genomic Biomarkers to Guide Immunotherapy in Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Zakile A Mfumbilwa, Martijn J H G Simons, Bram L T Ramaekers, Valesca P Retèl, Joanne M Mankor, Harry J M Groen, Joachim G J V Aerts, Manuela A Joore, Janneke A Wilschut, Veerle M H Coupé
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy. PharmacoEconomics 42 (4) (2024)
Zakile A Mfumbilwa, Martijn J H G Simons, Bram L T Ramaekers, Valesca P Retèl, Joanne M Mankor, Harry J M Groen, Joachim G J V Aerts, Manuela A Joore, Janneke A Wilschut, Veerle M H Coupé
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy. PharmacoEconomics 42 (4) (2024)
Zakile A Mfumbilwa, Martijn J H G Simons, Bram L T Ramaekers, Valesca P Retèl, Joanne M Mankor, Harry J M Groen, Joachim G J V Aerts, Manuela A Joore, Janneke A Wilschut, Veerle M H Coupé
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy. PharmacoEconomics 42 (4) (2024)
Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, Kim Monkhorst, Egbert F Smit, Lodewyk F A Wessels, Edwin Cuppen, Joachim G J V Aerts, Emile E Voest
Combining genomic biomarkers to guide immunotherapy in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Mandy van Gulijk, Anneloes van Krimpen, Sjoerd T T Schetters, Mike Eterman, Marit J van Elsas, Joanne M Mankor, Larissa Klaase, Marjolein J W de Bruijn, Menno van Nimwegen, Tim van Tienhoven, Wilfred F J Van IJcken, Louis Boon, Johan M S van der Schoot, Martijn Verdoes, Ferenc A Scheeren, Sjoerd H Van der Burg, Bart N Lambrecht, Ralph Stadhouders, Floris Dammeijer, Joachim Aerts, Thorbald van Hall
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance. Science immunology 8 (83) (2023)
Mandy van Gulijk, Anneloes van Krimpen, Sjoerd T T Schetters, Mike Eterman, Marit J van Elsas, Joanne M Mankor, Larissa Klaase, Marjolein J W de Bruijn, Menno van Nimwegen, Tim van Tienhoven, Wilfred F J Van IJcken, Louis Boon, Johan M S van der Schoot, Martijn Verdoes, Ferenc A Scheeren, Sjoerd H Van der Burg, Bart N Lambrecht, Ralph Stadhouders, Floris Dammeijer, Joachim Aerts, Thorbald van Hall
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance. Science immunology 8 (83) (2023)
Mandy van Gulijk, Anneloes van Krimpen, Sjoerd T T Schetters, Mike Eterman, Marit J van Elsas, Joanne M Mankor, Larissa Klaase, Marjolein J W de Bruijn, Menno van Nimwegen, Tim van Tienhoven, Wilfred F J Van IJcken, Louis Boon, Johan M S van der Schoot, Martijn Verdoes, Ferenc A Scheeren, Sjoerd H Van der Burg, Bart N Lambrecht, Ralph Stadhouders, Floris Dammeijer, Joachim Aerts, Thorbald van Hall
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance. Science immunology 8 (83) (2023)
Martijn J H G Simons, Valesca P Retèl, Bram L T Ramaekers, Rogier Butter, Joanne M Mankor, Marthe S Paats, Joachim G J V Aerts, Zakile A Mfumbilwa, Paul Roepman, Veerle M H Coupé, Carin A Uyl-de Groot, Willem H van Harten, Manuela A Joore
Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer. PharmacoEconomics 39 (12) (2021)